These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29631702)

  • 21. [Childhood steroid-dependent idiopathic nephrotic syndrome: Predictive factors for the need of immunosuppressive treatment].
    Golay M; Douillard A; Nagot N; Fila M; Ichay L; Dalla Vale F; Tenenbaum J; Morin D
    Arch Pediatr; 2017 Nov; 24(11):1096-1102. PubMed ID: 28941627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
    Kyrieleis HA; Levtchenko EN; Wetzels JF
    Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclophosphamide in the treatment of focal segmental glomerulosclerosis.
    Martinelli R; Pereira LJ; Silva OM; Okumura AS; Rocha H
    Braz J Med Biol Res; 2004 Sep; 37(9):1365-72. PubMed ID: 15334202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
    Wu B; Mao J; Shen H; Fu H; Wang J; Liu A; Gu W; Shu Q; Du L
    Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome.
    Bajpai A; Bagga A; Hari P; Dinda A; Srivastava RN
    Pediatr Nephrol; 2003 Apr; 18(4):351-6. PubMed ID: 12700961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histopathological Spectrum and Short-Term Outcome of Treatment with Cyclophosphamide in Relapsing Steroid-Sensitive Nephrotic Syndrome.
    Bajeer IA; Khatri S; Tresa V; Hashmi S; Mubarak M; Lanewala AA
    J Coll Physicians Surg Pak; 2018 Jun; 28(6):436-439. PubMed ID: 29848418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroid-dependent nephrotic syndrome in children: histopathology and relapses after cyclophosphamide treatment.
    Siegel NJ; Gaudio KM; Krassner LS; McDonald BM; Anderson FP; Kashgarian M
    Kidney Int; 1981 Mar; 19(3):454-9. PubMed ID: 7241883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook.
    Vester U; Kranz B; Zimmermann S; Hoyer PF
    Pediatr Nephrol; 2003 Jul; 18(7):661-4. PubMed ID: 12750975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up in children with steroid-resistant nephrotic syndrome.
    Besbas N; Topaloglu R; Saatci O; Bakkaloglu A
    Clin Pediatr (Phila); 1992 May; 31(5):283-8. PubMed ID: 1582094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
    Ponticelli C; Edefonti A; Ghio L; Rizzoni G; Rinaldi S; Gusmano R; Lama G; Zacchello G; Confalonieri R; Altieri P
    Nephrol Dial Transplant; 1993; 8(12):1326-32. PubMed ID: 8159300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mycophenolate mofetil (MMF) as the first choice immunosuppressive drug in treatment of steroid-dependent nephrotic syndrome in children].
    Ogarek I; Szczęsny-Choruz E; Wierzchowska-Słowiaczek E; Kwinta-Rybicka J; Stec Z; Moczulska A; Wilkosz K; Drożdż D
    Pol Merkur Lekarski; 2018 Apr; 44(262):192-195. PubMed ID: 29775447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome.
    Sinha A; Bhatia D; Gulati A; Rawat M; Dinda AK; Hari P; Bagga A
    Nephrol Dial Transplant; 2015 Jan; 30(1):96-106. PubMed ID: 25121488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood idiopathic steroid resistant nephrotic syndrome in Southwestern Nigeria.
    Olowu WA; Adelusola KA; Adefehinti O
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):979-90. PubMed ID: 20814150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
    Sinha MD; MacLeod R; Rigby E; Clark AG
    Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery.
    Sellier-Leclerc AL; Baudouin V; Kwon T; Macher MA; Guérin V; Lapillonne H; Deschênes G; Ulinski T
    Nephrol Dial Transplant; 2012 Mar; 27(3):1083-9. PubMed ID: 21810762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is cyclophosphamide effective in patients with IgM-positive minimal change disease?
    Geier P; Roushdi A; Skálová S; Vethamuthu J; Weiler G; Feber J
    Pediatr Nephrol; 2012 Dec; 27(12):2227-31. PubMed ID: 22729760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The response to cyclophosphamide in steroid-sensitive nephrotic syndrome is influenced by polymorphic expression of glutathion-S-transferases-M1 and -P1.
    Vester U; Kranz B; Zimmermann S; Büscher R; Hoyer PF
    Pediatr Nephrol; 2005 Apr; 20(4):478-81. PubMed ID: 15717164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
    Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.